Celularity, a biotech company specializing in placental-derived allogeneic cell therapies, will be showcasing data at the upcoming ASGCT Annual Meeting, showcasing the potential of their off-the-shelf natural killer (NK) cells to combat age-related diseases.
Related Keywords
Robert Hariri , , Pharma Reporter , Bio Developments , Markets Amp Regulations , Emerging Markets , Senescent Cells , Biotech , Biotech Companies , Clinical Trials ,
comparemela.com © 2020. All Rights Reserved.